KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Repligen (RGEN) over the last 15 years, with Q3 2025 value amounting to -$185000.0.

  • Repligen's Exchange Rate Effect fell 11925.08% to -$185000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 15374.89%. This contributed to the annual value of -$77000.0 for FY2024, which is 9934.41% up from last year.
  • According to the latest figures from Q3 2025, Repligen's Exchange Rate Effect is -$185000.0, which was down 11925.08% from $987000.0 recorded in Q2 2025.
  • Repligen's 5-year Exchange Rate Effect high stood at $9.8 million for Q4 2022, and its period low was -$8.3 million during Q3 2022.
  • In the last 5 years, Repligen's Exchange Rate Effect had a median value of -$2.1 million in 2022 and averaged -$1.3 million.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 34101.17% in 2022, then soared by 30225.41% in 2025.
  • Repligen's Exchange Rate Effect (Quarter) stood at -$4.9 million in 2021, then soared by 301.58% to $9.8 million in 2022, then tumbled by 168.84% to -$6.7 million in 2023, then soared by 63.34% to -$2.5 million in 2024, then skyrocketed by 92.52% to -$185000.0 in 2025.
  • Its Exchange Rate Effect was -$185000.0 in Q3 2025, compared to $987000.0 in Q2 2025 and $4.0 million in Q1 2025.